Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Sarah Billups to Calcium Channel Blockers

This is a "connection" page, showing publications Sarah Billups has written about Calcium Channel Blockers.

 
Connection Strength
  
 
 
0.291
  
  1. Billups SJ, Carter BL. Mibefradil withdrawn from the market. Ann Pharmacother. 1998 Jul-Aug; 32(7-8):841.
    View in: PubMed
    Score: 0.146
  2. Billups SJ, Carter BL. Mibefradil: a new class of calcium-channel antagonists. Ann Pharmacother. 1998 Jun; 32(6):659-71.
    View in: PubMed
    Score: 0.145
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)